Status of a group BNeisseria meningitidis vaccine
- 1 December 1985
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 4 (6) , 533-536
- https://doi.org/10.1007/bf02013388
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985
- SAFETY OF VACCINES CONTAINING MENINGOCOCCAL GROUP B POLYSACCHARIDEThe Lancet, 1984
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Clinical and Serological Evaluation of a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W135Experimental Biology and Medicine, 1982
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979
- Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.The Journal of Experimental Medicine, 1978
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- Meningococcal meningitis in Royal Air Force recruitsPublic Health, 1977
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972